What is Adalimumab?

Category: Prescription Drugs

Most popular types: Humira Humira Pen Humira Pen Crohn's Disease Starter Package Show all

false

Adalimumab is an injectable product that can be used to treat a variety of autoimmune conditions including: rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, and plaque psoriasis.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Rheumatoid arthritis 336 197
Crohn's disease 216 108
Psoriasis 114 52
Ankylosing spondylitis 84 48
Psoriatic arthritis 75 58
Ulcerative colitis 25 19

Show all 49 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 59
Moderate 80
Mild 108
None 196

Commonly reported side effects and conditions associated with Adalimumab

Side effect Patients Percentage
Headaches 17
Fatigue 16
Nausea 16
Weakened immune system 15
Injection site pain 11
Injection site itching 9

Show all 145 reported side effects

Dosages

Based on patients currently taking Adalimumab

Dosage Patients Percentage
1 mixed every other week 5
40 mg/0.8 mL every other week 5
50 mg every other week 5
40 mg every other week 4
100 mg every other week 3
40 mg weekly 2
50 mg weekly 2
1 other every other week 1
40 mg/0.8 mL monthly 1
40 mg/0.8 mL weekly 1

See all 11 dosages

Why patients stopped taking Adalimumab

Multiple reasons could be selected

Reason Patients Percentage
Did not seem to work 178
Side effects too severe 96
Doctor's advice 80
Other 40
Expense 15
Change in health plan coverage 11
Personal research 8
Course of treatment ended 7
See all 303 patients who've stopped taking Adalimumab

Duration

Currently taking Adalimumab

Duration Patients Percentage
1 - 6 months 1
6 months - 1 year 3
1 - 2 years 3
2 - 5 years 15
5 - 10 years 8
10 years or more 5

Stopped taking Adalimumab

Duration Patients Percentage
Less than 1 month 53
1 - 6 months 67
6 months - 1 year 73
1 - 2 years 45
2 - 5 years 50
5 - 10 years 11
10 years or more 6
Adherence
Adherence Evaluations Percentage
Always 368
Usually 48
Sometimes 7
Never taken as prescribed 20
Burden
Burden Evaluations Percentage
Very hard to take 34
Somewhat hard to take 88
A little hard to take 122
Not at all hard to take 199
Cost per month
Cost per month Evaluations Percentage
$200+ 30
$100-199 3
$50-99 17
$25-49 22
< $25 209
Not specified 162

What people switch to and from

Patients started taking Adalimumab after stopping:

Treatment Patients Percentage
Etanercept (Enbrel SureClick) 50
Infliximab (Remicade) 45
Methotrexate (Trexall) 34
Mesalamine (Pentasa) 10
Sulfasalazine (Salazopyrin) 9

Show all 38 treatments patients report switching from

Patients stopped taking Adalimumab and switched to:

Treatment Patients Percentage
Etanercept (Enbrel SureClick) 27
Infliximab (Remicade) 19
Certolizumab (Cimzia) 15
Abatacept (Orencia) 14
Methotrexate (Trexall) 9

Show all 22 treatments patients report switching to

Last updated:

18 patient evaluations for Adalimumab

Dec 31, 2019 (Started Jan 07, 2019)

  • Effectiveness
    None (for rheumatoid arthritis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Advice & Tips: Hymiroz was my 2.end TNFalfa inhibitor, and I don't believe I had any benefit at all from this one. The injection pen was somewhat better than the Benepali pen.
Cost: < $25 monthly

  • 0 helpful marks

Dec 11, 2019 (Started Oct 24, 2018)

  • Effectiveness
    Moderate (for rheumatoid arthritis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 1 other Every Other Week
Cost: < $25 monthly

Nov 1, 2018 (Started Oct 24, 2018)

  • Effectiveness
    Can't tell (for rheumatoid arthritis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 1 other Every Other Week
Advice & Tips: I just started taking this so I cannot really give a good evaluation, but I did notice the burning pain in my spine almost disappear 2 hours after the Dr gave me my first dose. The pain is back in my joints and back. I am waiting for the Insurance to approve my next dose.
Cost: < $25 monthly

  • 0 helpful marks

Aug 21, 2016 (Started Jul 01, 2007)

  • Effectiveness
    None (for rheumatoid arthritis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Cost: < $25 monthly

Jun 30, 2008 (Started Jul 01, 2007)

  • Effectiveness
    None (for rheumatoid arthritis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 50 mg Weekly
Cost: < $25 monthly

  • 0 helpful marks
Last updated:
Showing 3 of 18 patient evaluations for Adalimumab